These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35185154)

  • 21. Renal transplantation after recovery from COVID-19 - a case report with implications for transplant programs in the face of the ongoing corona-pandemic.
    Tuschen K; Anders J; Elfanish A; Schildgen V; Schildgen O; Becker JU; Weidemann A
    BMC Nephrol; 2021 Jul; 22(1):251. PubMed ID: 34229622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lung transplantation. Progress and perspectives].
    Cicconetti F; Sapienza P; La Rovere C; Teneriello GF
    Minerva Chir; 1995 Apr; 50(4):359-65. PubMed ID: 7675284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.
    Kueckelhaus M; Fischer S; Seyda M; Bueno EM; Aycart MA; Alhefzi M; ElKhal A; Pomahac B; Tullius SG
    Transpl Int; 2016 Jun; 29(6):655-62. PubMed ID: 26265179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacologic strategies in the prevention and treatment of corneal transplant rejection.
    Tabbara KF
    Int Ophthalmol; 2008 Jun; 28(3):223-32. PubMed ID: 17634865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Innate immunity processes in organ allografting--their contribution to acute and chronic rejection.
    Olszewski WL
    Ann Transplant; 2005; 10(2):5-9. PubMed ID: 16218025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Innate immunity and resistance to tolerogenesis in allotransplantation.
    Benichou G; Tonsho M; Tocco G; Nadazdin O; Madsen JC
    Front Immunol; 2012; 3():73. PubMed ID: 22566954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges.
    Malik JA; Ahmed S; Mir A; Shinde M; Bender O; Alshammari F; Ansari M; Anwar S
    J Infect Public Health; 2022 Feb; 15(2):228-240. PubMed ID: 35042059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kidney Transplantation in Times of Covid-19: Decision Analysis in the Canadian Context.
    Yanev I; Gagnon M; Cheng MP; Paraskevas S; Kumar D; Dragomir A; Sapir-Pichhadze R
    Can J Kidney Health Dis; 2021; 8():20543581211040332. PubMed ID: 34540237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Xenograft rejection: molecular mechanisms and therapeutic prospects.
    Azimzadeh A; Meyer C; Ravanat C; Cazenave JP; Wolf P
    Hematol Cell Ther; 1996 Aug; 38(4):331-43. PubMed ID: 8891725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Reconsidering the technical aspects and quality management background of faecal microbiota transplantation due to the novel coronavirus pandemic].
    Nagy GG; Tudlik Z; Gergely L; Kónya J; Orosi P; Rákóczi É; Szabó J; Várvölgyi C; Vitális E; Paragh G
    Orv Hetil; 2020 Nov; 161(44):1858-1871. PubMed ID: 33130602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Innate immunity and organ transplantation: focus on lung transplantation.
    Kreisel D; Goldstein DR
    Transpl Int; 2013 Jan; 26(1):2-10. PubMed ID: 22909350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Blood levels of cyclosporine, acute rejections and the prognosis of the allografts in pediatric renal allograft recipients].
    Sakuma T; Ogawa O; Kawamura T; Hasegawa A; Kamidono S
    Nihon Hinyokika Gakkai Zasshi; 1995 Sep; 86(9):1450-9. PubMed ID: 7474634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Medication Adherence Promotion System to Reduce Late Kidney Allograft Rejection: A Quality Improvement Study.
    Hooper DK; Varnell CD; Rich K; Carle A; Huber J; Mostajabi F; Dahale D; Pai ALH; Goebel J; Modi AC
    Am J Kidney Dis; 2022 Mar; 79(3):335-346. PubMed ID: 34352285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pulmonary innate immune response in Sars-cov-2 infection].
    Bottino E; Ponce AA
    Rev Fac Cien Med Univ Nac Cordoba; 2022 Mar; 79(1):33-42. PubMed ID: 35312259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. M2 Macrophages Serve as Critical Executor of Innate Immunity in Chronic Allograft Rejection.
    Zhang H; Li Z; Li W
    Front Immunol; 2021; 12():648539. PubMed ID: 33815407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung transplant immunosuppression - time for a new approach?
    Witt CA; Puri V; Gelman AE; Krupnick AS; Kreisel D
    Expert Rev Clin Immunol; 2014 Nov; 10(11):1419-21. PubMed ID: 25220652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions.
    Elens L; Langman LJ; Hesselink DA; Bergan S; Moes DJAR; Molinaro M; Venkataramanan R; Lemaitre F
    Ther Drug Monit; 2020 Jun; 42(3):360-368. PubMed ID: 32304488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Xenotransplantation: Current Status in Preclinical Research.
    Lu T; Yang B; Wang R; Qin C
    Front Immunol; 2019; 10():3060. PubMed ID: 32038617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mechanisms of rejection in solid organ transplantation.
    Cozzi E; Colpo A; De Silvestro G
    Transfus Apher Sci; 2017 Aug; 56(4):498-505. PubMed ID: 28916402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The impact of the COVID‒19 pandemic on organ donation and transplantation in Hungary in 2020].
    Mihály S; Egyed-Varga A; Trnka-Szántay K; Deme O; Holtzinger E; Nacsa J; Piros L
    Orv Hetil; 2021 Jun; 162(23):890-896. PubMed ID: 34091437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.